| ²é¿´: 28 | »Ø¸´: 0 | |||
yexuqingľ³æÖ®Íõ (ÎÄѧ̩¶·)
Ì«ÑôϵϵÖ÷ÈÎ
|
[½»Á÷]
ÓÎÀëDNAȾɫÖÊ״̬¼ì²â¼¼Êõ½Òʾ¼²²¡ÆðÔ´ÓëÖÎÁÆÓ¦´ð
|
|
±±Ò½ÈýÔº¾°ºì÷ÍŶÓÓëºÏ×÷ÕßÔÚNatureÉÏ·¢±íÑо¿³É¹û cf-EpiTracing¼¼ÊõΪÁܰÍÁö¾«×¼ÕïÁÆ¿ª±ÙÎÞ´´Ð·¾¶ ×÷ÕߣºÕÅΰÁú À´×Ô£ºÑªÒºÄÚ¿Æ Ê±¼ä£º2026-03-05 ÎÄÕµã»÷ÂÊ£º102 2026Äê3ÔÂ4ÈÕ£¬±±¾©´óѧδÀ´¼¼ÊõѧԺ¡¢±±¾©´óѧ-Ç廪´óѧÉúÃü¿ÆÑ§ÁªºÏÖÐÐĺΰ®±òÍŶӣ¬ÁªºÏ±±¾©´óѧµÚÈýҽԺѪҺÄڿƾ°ºì÷ÍŶӡ¢ÖйúÈËÃñ½â·Å¾ü×ÜҽԺѪҺ²¡Ò½Ñ§²¿ñ¼Á¢Æ¼ÍŶӺÍÉϺ£½»Í¨´óѧҽѧԺ»ù´¡Ò½Ñ§ÔºÖ£¿¡¿ËÍŶÓÔÚ¹ú¼ÊȨÍþÆÚ¿¯Nature£¨¡¶×ÔÈ»¡·£©ÉÏ£¬ÔÚÏß·¢±íÁËÌâΪ¡°Cell-free chromatin state tracing reveals disease origin and therapy responses¡±£¨ÓÎÀëDNAȾɫÖÊ״̬¼ì²â¼¼Êõ½Òʾ¼²²¡ÆðÔ´ÓëÖÎÁÆÓ¦´ð£©µÄÎÄÕ¡£ ¸ÃÑо¿¿ª·¢ÁËÒ»ÏîÃûΪcf-EpiTracing£¨cell-free EpiTracing£©µÄ´´ÐÂÒºÌå»î¼ì¼¼Êõƽ̨£¬Í¨¹ý¼ì²âѪ½¬ÖÐÓÎÀëȾɫÖʵĶà×éµ°°×ÐÞÊÎÐÅÏ¢£¬½áºÏ»úÆ÷ѧϰËã·¨£¬ÊµÏÖÁ˶Լ²²¡ÊÜÀÛ×éÖ¯ºÍϸ°ûÀàÐ͵ĸßÁéÃô¶ÈÎÞ´´Ê¶±ð£¬ÔÚÁܰÍÁöÕïÖεÄÁÙ´²Ó¦ÓÃÖÐÕ¹ÏÖ³ö¾Þ´óDZÁ¦¡£ |
» ²ÂÄãϲ»¶
²©Ê¿ºóСº¢ÉÏѧ
ÒѾÓÐ1È˻ظ´
»ù½ðί:µ±Ç°ÏîÄ¿ÆÀÉó¹¤×÷ÔÚÆ½ºâ¿ÆÑ§ÐÔÓ빫ÕýÐÔ·½ÃæÓöµ½Á˼«´óÌôÕ½
ÒѾÓÐ2È˻ظ´
ÖÐҩѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ67È˻ظ´
½ñÌì¿ÉÄܹ«²¼Âð
ÒѾÓÐ3È˻ظ´
½ñÌìÀí½âÐÒ´æÕ߯«²îµÄº¬Òå¡£
ÒѾÓÐ6È˻ظ´
д¸øÊ§ÒâÖеijæÓѺÍʧÒâ¹ýµÄÈË
ÒѾÓÐ27È˻ظ´
NCÒ»¸ö
ÒѾÓÐ10È˻ظ´
ÁÙ´²Ò½Ñ§³õÊÔ306£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ4È˻ظ´














»Ø¸´´ËÂ¥
30